Diabetes affects more than 30 million Americans – and about one-quarter are unaware they have the disease.
Diabetes is a complex, chronic illness that requires consistent medical care and treatment to help control blood sugar levels and prevent acute or long-term complications of the disease, such as kidney failure and amputations.
According to the American Diabetes Association, most Americans with diabetes have type 2, in which relative insulin deficiency combines with the body failing to properly use insulin. More than 30 million people in the United States have diabetes, up from the previous estimate of 29 million in 2013, according to a report from the Centers for Disease Control and Prevention. And an estimated 7 million people have the disease but are unaware.
As the 7th leading cause of death in the United States, diabetes has far-reaching implications for patients and for our health care system. There are currently 171 medicines in the pipeline to treat diabetes and related conditions, either in clinical trials or awaiting approval from the FDA. These medicines represent an exciting new chapter in the ongoing quest to better treat this debilitating disease.
30 Million Americans Afflicted
Approximately 1.5 million American children and adults have type 1 diabetes and of the 30 million Americans living with diabetes, 7 million are undiagnosed. An additional 86 million Americans have prediabetes. Without weight loss and moderate physical activity, 15 to 30 percent of people with prediabetes will develop type 2 diabetes within five years.Read the Report Now
I'm Not Average: Kady H.
She was diagnosed with type 1 diabetes (T1D), which was a shock because she had no family history of this disease. This deadly disease, while frightening and new, was manageable once Kady and her family became educated about T1D and were able to take steps to treat it. However, she needs multiple insulin shots a day to manage her blood glucose levels and stay alive. Although the disease permeates every aspect of her life, Kady has never let T1D stop her from pursuing her dreams and goals. She embraces new therapies and technologies that make living with T1D easier, and remains optimistic about improved therapies that will continue to lessen the burden of her disease until there is a cure.
Underdiagnosis and Undertreatment
Controlling diabetes is crucial to preventing complications like kidney failure and stroke. Out of 30 million Americans with diabetes, only 23 million are diagnosed, 19 million are treated, and only 8 million are successfully treated and living with controlled diabetes. The other 22 million Americans live with uncontrolled diabetes.
Diabetes Medicines in the Pipeline
Researching and developing new medicines for diabetes is particularly difficult, with scientific and regulatory challenges introducing unique hurdles for researchers to navigate. Still, biopharmaceutical research companies continue to explore different approaches to fight diabetes and its related conditions. Among the 171 medicines in the development pipeline today.
New Cases Diagnosed Annually
Diabetes is now the 7th leading cause of death in the United States. It is also the leading cause of kidney failure, non-traumatic lower limb amputations, and new cases of blindness among adults.Get the Facts
Medicines in the Pipeline
America’s biopharmaceutical research companies are developing over 170 medicines for diabetes and diabetes-related conditions, such as chronic kidney failure due to diabetes and painful diabetic neuropathy. These medicines in development include 40 for type 1 diabetes, 95 for type 2 and 61 for diabetes-related conditions. Read our report on the new frontier in treatments for type 1 diabetes and other challenging autoimmune diseases, and learn more about other diabetes medicines currently in development.
Addressing Type 1 and 2 Diabetes Simultaneously
A potential first-in-class oral medicine in development provides a new way to address type 1 and 2 diabetes by acting on two different targets in the body. It works by inhibiting both sodium-glucose co-transporter types 1 and 2 (SGLT1 and SGLT2), molecules that also help move glucose in and out of the body’s cells.
Fighting Diabetic Kidney Disease
A medicine in development for diabetic neuropathy is a selective endothelin-A receptor antagonist. The medicine has been shown to reduce albuminuria and prevent the progression of the condition by blocking the effects of endothelin-I, a peptide that signals blood vessels to constrict or dilate.
Fighting Type 1 Diabetes by Modifying the Immune System
A fully recombinant monoclonal antibody is in development for treating patients with newly-diagnosed type 1 diabetes. The medicine targets the interleukin-21 protein, which is involved in communication between cells and helps regulate the immune system. The medicine may help mitigate attacks on the pancreas and preserve beta cells.
Easier Treatment Routines
Additional advances in diabetes medications offer better glycemic control, reduced pill burden, easier delivery mechanisms, fewer injections, and easier daily routines. These advances help increase adherence, which has been shown to result in many fewer hospitalizations and emergency department visits each year.
View the full 2016 Medicines in Development for Diabetes Report.
Learn about the specific medicines and treatments currently in development for diabetes and diabetes-related conditions.
The disease is one of the leading killers of Americans and the epidemic is quickly escalating.
Download the infographic on medicines in development for Diabetes
What are our greatest challenges as we address managing chronic diseases like diabetes?
View the infographic to learn how various patients with diabetes save with Medicare Part D.
Managing diabetes treatments is a big task. Medicare Part D helps patients access needed medicines, keeps costs low and helps avoid costly hospitalizations and complications.
How can we best promote healthy lifestyles and adherence to needed medicines to tackle diabetes?